Update on extracorporeal membrane oxygenation

Dorson, 1969, A perfusion system for infants, Trans Am Soc Artif Intern Organs, 15, 155 White, 1971, Prolonged respiratory support in newborn infants with a membrane oxygenator, Surgery, 70, 228 Hill, 1972, Extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome): use of the Bramson Membrane Lung, N Engl J Med, 286, 629, 10.1056/NEJM197203232861204 Zapol, 1979, Extracorporeal membrane oxygenation in severe respiratory failure, J Am Med Assoc, 242, 2193, 10.1001/jama.242.20.2193 Bartlett, 1985, Esperanze (ASAIO Presidential Address), Trans ASAIO, 30, 725 Bartlett, 1982, Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 45 cases, Surgery, 92, 425 2000, ECMO and advanced therapies for respiratory failure 2001, ECMO and advanced therapies for respiratory failure Zwischenberger, 1995, Extracorporeal cardiopulmonary support in critical care, Extracorporeal Life Support Organization, 315 Dickey, 1993, Neonates requiring cardiopulmonary resuscitation before extracorporeal membrane oxygenation: prognostic factors for survival and neurologic outcome, 32 Allare, 1993, Is CPR or medical resuscitation a contra-indication to neonatal ECMO? Long-term outcomes of neonates post resuscitation and ECMO: The Phoenix Experience, 31 Marsh, 1988, Extracorporeal membrane oxygenation selection criteria: Partial pressure of arterial oxygen versus alveolar-arterial oxygen gradient, Pediatrics, 82, 162, 10.1542/peds.82.2.162 Krummel, 1984, Alveolar-arterial oxygen gradients versus the neonatal pulmonary insufficiency index for prediction of morality in ECMO candidates, J Pediatric Surg., 19, 380, 10.1016/S0022-3468(84)80257-2 Otriz, 1987, Extracorporeal membrane oxygenation in pediatric respiratory failure, Pediatr Clin N Am, 34, 39, 10.1016/S0031-3955(16)36179-X Beck, 1986, Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn, J Pediatr Surg., 21, 297, 10.1016/S0022-3468(86)80188-9 Abman, 1995, Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn: mechanisms underlying variable clinical responses, Hot Topics Neonatol Graziani, 1997, Clinical antecedents of neurologic and audiologic abnormalities in survivors of neonatal extracorporeal membrane oxygenation, J Child Neurol, 12, 415, 10.1177/088307389701200702 Fujimoto, 1994, Hypocarbia and cystic periventricular leukomalacia in premature infants, Arch Dis Child, 71, F107, 10.1136/fn.71.2.F107 Ikonen, 1992, Hyperbilirubinemia, hypocarbia and periventricular leukomalacia in preterm infants — relationship to cerebral palsy, Acta Paediatr, 81, 802, 10.1111/j.1651-2227.1992.tb12107.x Iida, 1992, Etiologies and distribution of neonatal leukomalacia, Pediatr Neurol, 8, 205, 10.1016/0887-8994(92)90069-B Gleason, 1989, Cerebral blood flow and metabolism during and after prolonged hypocapnia in newborn lambs, J Pediatr, 115, 309, 10.1016/S0022-3476(89)80091-5 Box, 1993, Persistent pulmonary hypertension in high-risk congenital diaphragmatic hernia patients: Incidence and vasodilator therapy, J Pediatr Surg, 28, 1463, 10.1016/0022-3468(93)90431-J Kinsella, 1993, Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide, J Pediatr, 123, 103, 10.1016/S0022-3476(05)81551-3 Reddig, 1984, Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in awake piglets, Am Rev Respir Dis, 129, 785, 10.1164/arrd.1984.129.5.785 Feltes, 1986, Effects of dopamine and nifedipine infusions on the pulmonary circulation of the lamb, Pediatr Pharmacol, 5, 261 Coe, 1987, Bipyridine derivatives lower arteriolar resistance and improve left ventricular function in newborn lambs, Pediatr Res, 22, 422, 10.1203/00006450-198710000-00012 Kuhl, 1989, Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension, Arch Dis Child, 64, 949, 10.1136/adc.64.7_Spec_No.949 Cassin, 1981, Effects of prostacyclin on the fetal pulmonary circulation, Pediatr Pharmacol, 1, 197 Tolsa, 1995, Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn, Arch Dis Child, 72, F184, 10.1136/fn.72.3.F184 Abu-Osba, 1992, Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate, Arch Dis Child, 67, 31, 10.1136/adc.67.1_Spec_No.31 Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0 Frostell, 1993, Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation, Anesthesiol, 78, 427, 10.1097/00000542-199303000-00005 Day, 1996, Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension, Pediatr, 98, 698, 10.1542/peds.98.4.698 Barefield, 1996, Inhaled nitric oxide for near-term infants with hypoxemic respiratory failure, J Pediatr, 129, 279, 10.1016/S0022-3476(96)70255-X 1997, Inhaled nitric oxide for near-term infants with respiratory failure, N Engl J Med, 336, 602 Roberts, 1997, Inhaled nitric oxide and persistent pulmonary hypertension of the newborn, N Engl J Med, 336, 605, 10.1056/NEJM199702273360902 Kinsella, 1997, Randomized, multicenter trial of inhaled nitric oxide and high-frequency ventilation in severe persistent pulmonary hypertension of the newborn, J Pediatr, 131, 55, 10.1016/S0022-3476(97)70124-0 Wessel, 1997, Improved oxygenation in a randomized trial of inhaled nitric oxide for PPHN, Pediatr, 100 Davidson, 1998, Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study, Pediatr, 101, 325, 10.1542/peds.101.3.325 Mercier, 1999, (Mercier JC/Hop Robert Debre/48 Blvd Serurier/F 75019 Paris/FRANCE). Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial, Lancet, 354, 1066, 10.1016/S0140-6736(99)03309-7 Clark, 2000, Low-Dose Nitric Oxide Therapy for persistent pulmonary hypertension of the newborn, N Engl J Med, 342, 469, 10.1056/NEJM200002173420704 Lewis, 1993, Surfactant and the adult respiratory distress syndrome, Am Rev Respir Dis, 147, 218, 10.1164/ajrccm/147.1.218 Bui, 1992, Phospholipid and surfactant protein concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation, J Pediatr, 121, 271, 10.1016/S0022-3476(05)81202-8 Lotze, 1998, Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure, J Pediatr, 132, 40, 10.1016/S0022-3476(98)70482-2 Cornish, 1987, Extracorporeal membrane oxygenation and high-frequency oscillatory ventilation: potential therapeutic relationships, Crit Care Med, 15, 831, 10.1097/00003246-198709000-00006 Carter, 1990, High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure, Pediatr, 85, 159, 10.1542/peds.85.2.159 Clark, 1994, Prospective randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation, J Pediatr, 124, 447, 10.1016/S0022-3476(94)70374-4 Zwischenberger, 2000 Zwischenberger, 1995, Extracorporeal cardiopulmonary support in critical care, Extracorporeal Life Support Organization, 95 McKay, 1996, Stenting extracorporeal membrane oxygenation cannulae in the neonate: is it safe?, 76 2001 Anonymous. UK collaborative randomized trial of neonatal ECMO. UK Collaborative ECMO Trial Group. Lancet 348. 1996 Glass P, Wagner AE, Coffman C. Outcome and follow-up of neonates treated with ECMO. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, 2nd edition. Chapter 22, pp. 409–420. Glass, 1993, Patient neurodevelopmental outcomes after neonatal ECMO Schumacher, 1991, Follow-up of infants treated with ECMO for newborn respiratory failure, Pediatrics, 87, 451, 10.1542/peds.87.4.451 Glass, 1989, Morbidity for survivors of extracorporeal membrane oxygenation: neurodevelopmental outcome at 12 years of age, Pediatrics, 83, 72, 10.1542/peds.83.1.72 Stewart, 1990, Inclusion of late deaths changes true survival of ECMO patients Stolar, 1993, Extracorporeal life support organization 1993: registry report, AAIO J, 39, 976 Stewart, 1992, Extracorporeal life support (ECLS) infants with total anomalous pulmonary venous drainage (TAPVD): review of the ELSO registry, 81